These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25451526)

  • 21. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection.
    Encke J; Findeklee J; Geib J; Pfaff E; Stremmel W
    Clin Exp Immunol; 2005 Nov; 142(2):362-9. PubMed ID: 16232225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.
    Cerny A; Chisari FV
    Hepatology; 1999 Sep; 30(3):595-601. PubMed ID: 10462362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural killer cells: primary target for hepatitis C virus immune evasion strategies?
    Golden-Mason L; Rosen HR
    Liver Transpl; 2006 Mar; 12(3):363-72. PubMed ID: 16498647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic analysis of the role of innate immunity in SEIS epidemic model.
    Jain S; Kumar S
    Eur Phys J Plus; 2021; 136(4):439. PubMed ID: 33936924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C virus and the immune system: a concise review.
    Gremion C; Cerny A
    Rev Med Virol; 2005; 15(4):235-68. PubMed ID: 15782389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell inhibition is connected to exhaustion of CD8+ T cell polyfunctionality during chronic hepatitis C virus infection.
    Rodrigue-Gervais IG; Rigsby H; Jouan L; Sauvé D; Sékaly RP; Willems B; Lamarre D
    J Immunol; 2010 Mar; 184(6):3134-44. PubMed ID: 20173023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of backward bifurcation in a model of hepatitis B and C viruses.
    Qesmi R; Wu J; Wu J; Heffernan JM
    Math Biosci; 2010 Apr; 224(2):118-25. PubMed ID: 20085774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Hopf bifurcation analysis of an susceptible-infective-removed epidemic model incorporating media coverage with time delay.
    Zhao H; Zhao M
    J Biol Dyn; 2017 Dec; 11(1):8-24. PubMed ID: 27627694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive immune responses in acute and chronic hepatitis C virus infection.
    Bowen DG; Walker CM
    Nature; 2005 Aug; 436(7053):946-52. PubMed ID: 16107834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic analysis of a fractional-order delayed model for hepatitis B virus with CTL immune response.
    Shi R; Lu T; Wang C
    Virus Res; 2020 Feb; 277():197841. PubMed ID: 31887328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus--T-cell responses and viral escape mutations.
    Petrovic D; Dempsey E; Doherty DG; Kelleher D; Long A
    Eur J Immunol; 2012 Jan; 42(1):17-26. PubMed ID: 22125159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential characteristics of primary infection and re-infection can cause backward bifurcation in HCV transmission dynamics.
    Nazari F; Gumel AB; Elbasha EH
    Math Biosci; 2015 May; 263():51-69. PubMed ID: 25686692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection.
    Szabo G; Dolganiuc A
    Immunobiology; 2005; 210(2-4):237-47. PubMed ID: 16164031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Impaired non-viral specific immune function of dendritic cell does not interfere with clearance and cytotoxic T lymphocyte response to HBV or HCV].
    Fan CL; Chen HS; Li RB; Wang SX; Cong X; Fei R; Jiang D; Wang Y; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Feb; 12(2):67-71. PubMed ID: 14980100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamical analysis of SEIS model with nonlinear innate immunity and saturated treatment.
    Jain S; Kumar S
    Eur Phys J Plus; 2021; 136(9):952. PubMed ID: 34549013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progressive liver injury in chronic hepatitis C infection is related to altered cellular immune response and to different citokine profile.
    Cecere A; Marotta F; Vangieri B; Tancredi L; Gattoni A
    Panminerva Med; 2004 Sep; 46(3):171-87. PubMed ID: 15510086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic hepatitis C virus infection established and maintained in chimpanzees independent of dendritic cell impairment.
    Rollier C; Drexhage JA; Verstrepen BE; Verschoor EJ; Bontrop RE; Koopman G; Heeney JL
    Hepatology; 2003 Oct; 38(4):851-8. PubMed ID: 14512872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of incidence function in backward bifurcation for malaria model with temporary immunity.
    Roop-O P; Chinviriyasit W; Chinviriyasit S
    Math Biosci; 2015 Jul; 265():47-64. PubMed ID: 25916889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.